Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer
Clinical trial NCT03078400 · UNKNOWN
Trial details
- NCT number
- NCT03078400
- Sponsor
- Splash Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-10
- Primary completion
- 2020-01-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.